Literature DB >> 9112223

Mixed connective tissue disease. A clinico-serological study of 17 cases.

I García-de la Torre1, M Salazar-Páramo, G Salmón-de la Torre.   

Abstract

Mixed connective tissue disease (MCTD) was described as a distinct clinical syndrome in 1972. Since then many cases have been reported in the literature worldwide. In this study we present our experience with a group of 17 Mexican patients with this syndrome, and we analyze their clinical and serological features, as well as the causes of death in these patients. The patients are Mexican mestizos living in Guadalajara and most of them have been followed-up at Hospital General de Occidente for a period of 1-10 years. The female/male ratio was 16:1, and their age ranged from 14-55 years with a mean of 29 years. The disease duration has ranged from 1-17 years, with a mean of 6 years. Among the clinical manifestations we have found a high frequency of lymphadenopathy when compared with published series (13/17 or 76%), and the laboratory findings in our patients included a very high polyclonal increase of gammaglobulins (93%), lymphopenia (76%), direct immunofluorescence speckled nuclear epidermal deposits in skin biopsies (75%) and positive rheumatoid factor (65%). Other clinical and serological features were similar to those reported in other series of patients with MCTD. Six of the 17 patients have died (35%), and in 3 of them (17.5%) the cause of death was due to an infectious disease that suddenly presented, and apparently was not related to a concomitant high dose of steroids or malnutrition in the patients. It seems that in addition to the already well known autoimmune abnormalities that occur in MCTD, there are other features like the presence of lymphadenopathy, the high polyclonal increase of gammaglobulins, and the lymphopenia, that reflect the profound disturbance of the immune system in this syndrome, possibly contributing to the sudden appearance of a severe infectious disease in some of our patients.

Entities:  

Mesh:

Year:  1996        PMID: 9112223     DOI: 10.1007/bf00351163

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

Review 1.  Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity?

Authors:  M A Lázaro; J A Maldonado Cocco; L J Catoggio; S M Babini; O D Messina; O García Morteo
Journal:  Medicine (Baltimore)       Date:  1989-01       Impact factor: 1.889

Review 2.  Structure of spliceosomal snRNPs and their role in pre-mRNA splicing.

Authors:  R Lührmann; B Kastner; M Bach
Journal:  Biochim Biophys Acta       Date:  1990-11-30

3.  Observations on the in vivo reaction of antinuclear antibodies with epidermal cells.

Authors:  G T Izuno
Journal:  Br J Dermatol       Date:  1978-04       Impact factor: 9.302

4.  Mixed connective tissue disease syndrome.

Authors:  J N Gilliam; S D Prystowsky
Journal:  Arch Dermatol       Date:  1977-05

5.  Mixed connective tissue disease: a subsequent evaluation of the original 25 patients.

Authors:  S H Nimelstein; S Brody; D McShane; H R Holman
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

6.  Suppressor cell loss and dysfunction in mixed connective tissue disease.

Authors:  D Alarcón-Segovia; A Ruíz-Arguelles
Journal:  Arthritis Rheum       Date:  1980-03

7.  Clinical characteristics and course in patients with high titer anti-RNP antibodies.

Authors:  J P Lemmer; N H Curry; J H Mallory; M V Waller
Journal:  J Rheumatol       Date:  1982 Jul-Aug       Impact factor: 4.666

8.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

Authors:  D Alarcón-Segovia; M H Cardiel
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

9.  Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes.

Authors:  M M Ward; E Pyun; S Studenski
Journal:  Arthritis Rheum       Date:  1995-02

10.  Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

Authors:  M Abu-Shakra; M B Urowitz; D D Gladman; J Gough
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more
  3 in total

1.  Rheumatoid factor isotypes in mixed connective tissue disease.

Authors:  Yoshihiro Mimura; Hironobu Ihn; Masatoshi Jinnin; Yoshihide Asano; Kenichi Yamane; Kunihiko Tamaki
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

Review 2.  [Mixed connective tissue disease: prevalence and clinical characteristics in African black, study of 7 cases in Gabon and review of the literature].

Authors:  Landry Missounga; Josaphat Iba Ba; Ingrid Rosalie Nseng Nseng Ondo; Maria Ines Carine Nziengui Madjinou; Doris Malekou; Emeline Gracia Mouendou Mouloungui; Emmanuel Ecke Nzengue; Jean Bruno Boguikouma; Moussavou Kombila
Journal:  Pan Afr Med J       Date:  2017-06-30

3.  Lymphocytic interstitial pneumonia in a patient with mixed connective tissue disease - A case report.

Authors:  Chin-Wei Kuo; Kung-Chao Chang; Han-Yu Chang; Tang-Hsiu Huang
Journal:  Respir Med Case Rep       Date:  2018-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.